Abbvie

Abbvie, a global biopharmaceutical company, was established in 2013 when it was spun off from Abbott Laboratories. Headquartered in North Chicago, Illinois, it specializes in a wide range of therapeutic areas. The company operates within several key business segments such as Immunology, Oncology, Neuroscience, Virology, Eye Care, and Aesthetics. Within Immunology, Abbvie offers treatments for autoimmune diseases like rheumatoid arthritis and psoriasis. Its Oncology segment provides therapies for different types of cancer, while the Neuroscience division focuses on conditions such as Parkinson's disease. Furthermore, the company has products in Virology to treat illnesses like hepatitis C and HIV, as well as treatments within Eye Care. The Aesthetics category covers cosmetic and corrective products. Some of Abbvie's leading brands include Humira, the biologic treatment for autoimmune diseases, and Imbruvica for certain cancers. Viekira Pak addresses chronic hepatitis C, Skyrizi caters to patients with plaque psoriasis, and Rinvoq is used for rheumatoid arthritis management. Abbvie markets its products and services on a global scale, including significant markets like the United States, Europe, and Japan, making its therapies accessible to patients in multiple countries worldwide. (Powered by AI)